Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Simon

Showing results (101-110 of 184) with videos related to

Pageof 19
Sort By:
Oncology Letters|March 22, 2016
<sup>18</sup>F-fluoroethyl-L-tyrosine positron emission tomography for the differential diagnosis of tumefactive multiple sclerosis versus glioma: A case reportSied Kebir, Florian C Gaertner, Marcus Mueller, et al.
Neuro-Oncology|September 19, 2025
EANS-EANO Guidelines on the extent of resection in gliomasRoland Goldbrunner, Nicolas Foroglou, Francesco Signorelli, et al.
Kidney International|April 17, 2004
Treatment of hyperphosphatemia in hemodialysis patients: The Calcium Acetate Renagel Evaluation (CARE Study)Wajeh Y Qunibi, Robert E Hootkins, Laveta L McDowell, et al.
International Journal of Cancer|March 12, 2014
Assessment and prognostic significance of the epidermal growth factor receptor vIII mutation in glioblastoma patients treated with concurrent and adjuvant temozolomide radiochemotherapyMichael Weller, Kerstin Kaulich, Bettina Hentschel, et al.
Nature Communications|December 12, 2024
Membrane potential states gate synaptic consolidation in human neocortical tissueFranz X Mittermaier, Thilo Kalbhenn, Ran Xu, et al.
Annals of Neurology|June 29, 2011
NOA-05 phase 2 trial of procarbazine and lomustine therapy in gliomatosis cerebriMartin Glas, Oliver Bähr, Jörg Felsberg, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 18, 2026
The functional impact of LGI1 autoantibodies on human CA3 pyramidal neuronsLaura Monni, Hans-Christian Kornau, Alice Podestà, et al.
Journal of Neuro-Oncology|January 21, 2014
Cilengitide treatment of newly diagnosed glioblastoma patients does not alter patterns of progressionGünter Eisele, Antje Wick, Anna-Carina Eisele, et al.
Journal of Cancer Research and Clinical Oncology|April 22, 2016
Phase I trial of dovitinib (TKI258) in recurrent glioblastomaNiklas Schäfer, Gerrit H Gielen, Sied Kebir, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 18, 2010
Genetic risk profiles identify different molecular etiologies for gliomaMatthias Simon, Fay J Hosking, Yannick Marie, et al.
Pageof 19

Showing results (101-110 of 184) with videos related to

Sort By:
Pageof 19
Oncology Letters|March 22, 2016
<sup>18</sup>F-fluoroethyl-L-tyrosine positron emission tomography for the differential diagnosis of tumefactive multiple sclerosis versus glioma: A case reportSied Kebir, Florian C Gaertner, Marcus Mueller, et al.
Neuro-Oncology|September 19, 2025
EANS-EANO Guidelines on the extent of resection in gliomasRoland Goldbrunner, Nicolas Foroglou, Francesco Signorelli, et al.
Kidney International|April 17, 2004
Treatment of hyperphosphatemia in hemodialysis patients: The Calcium Acetate Renagel Evaluation (CARE Study)Wajeh Y Qunibi, Robert E Hootkins, Laveta L McDowell, et al.
International Journal of Cancer|March 12, 2014
Assessment and prognostic significance of the epidermal growth factor receptor vIII mutation in glioblastoma patients treated with concurrent and adjuvant temozolomide radiochemotherapyMichael Weller, Kerstin Kaulich, Bettina Hentschel, et al.
Nature Communications|December 12, 2024
Membrane potential states gate synaptic consolidation in human neocortical tissueFranz X Mittermaier, Thilo Kalbhenn, Ran Xu, et al.
Annals of Neurology|June 29, 2011
NOA-05 phase 2 trial of procarbazine and lomustine therapy in gliomatosis cerebriMartin Glas, Oliver Bähr, Jörg Felsberg, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 18, 2026
The functional impact of LGI1 autoantibodies on human CA3 pyramidal neuronsLaura Monni, Hans-Christian Kornau, Alice Podestà, et al.
Journal of Neuro-Oncology|January 21, 2014
Cilengitide treatment of newly diagnosed glioblastoma patients does not alter patterns of progressionGünter Eisele, Antje Wick, Anna-Carina Eisele, et al.
Journal of Cancer Research and Clinical Oncology|April 22, 2016
Phase I trial of dovitinib (TKI258) in recurrent glioblastomaNiklas Schäfer, Gerrit H Gielen, Sied Kebir, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 18, 2010
Genetic risk profiles identify different molecular etiologies for gliomaMatthias Simon, Fay J Hosking, Yannick Marie, et al.
Pageof 19